Presentation is loading. Please wait.

Presentation is loading. Please wait.

Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma  Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide.

Published byRenáta Szabóné Modified over 5 years ago

Similar presentations

Presentation on theme: "Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma  Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide."— Presentation transcript:

1 Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma 
Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide Matsumura, MD, Kan Ideguchi, MD, Tsutomu Yasumitsu, MD, Katsuhiro Nakagawa, MD, Kenjiro Fukuhara, MD, Hajime Maeda, MD, Shin-ichi Takeda, MD, Masato Minami, MD, Yuko Ohno, PhD, Hikaru Matsuda, MD  The Annals of Thoracic Surgery  Volume 78, Issue 1, Pages (July 2004) DOI: /j.athoracsur

2 Fig 1 Overall survival of 128 patients who underwent curative resection for pulmonary metastases from colorectal carcinoma. The 5-year survival rate was 45.3%. Median survival time was 49.5 months. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

3 Fig 2 Probability of survival according to the number and location (unilateral or bilateral) of metastatic lesions. The 5-year survival rate for patients with solitary, multiple unilateral, and multiple bilateral metastases was 50.6%, 40.3%, and 12.5%, respectively. The survival rate for patients with multiple bilateral metastases was worse than with a solitary lesion (p = ) and with multiple unilateral lesions (p = ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

4 Fig 3 Probability of survival by Dukes' stage. The 5-year survival rate for patients with Dukes' A was 68.7% compared with 32.8% for patients with Dukes' B–D (significant, p = ). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

5 Fig 4 Probability of survival for patients who underwent a repeat pulmonary metastasectomy. The 3- and 5-year survival rates were 44.6% and 22.3%, respectively. Median survival time was 35.4 months. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

Download ppt "Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma  Masayoshi Inoue, MD, Mitsunori Ohta, MD, Keiji Iuchi, MD, Akihide."

Similar presentations

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Cytologically malignant margins of wedge resected stage I non-small cell lung cancer  Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer  Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,
Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.
B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 
Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis  Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.

Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis  Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Cavernoscopic Removal of a Fungus Ball for Pulmonary Complex Aspergilloma  Motoyasu Sagawa, MD, Tsutomu Sakuma, MD, Tsugimasa Isobe, MD, Makoto Sugita,

Cavernoscopic Removal of a Fungus Ball for Pulmonary Complex Aspergilloma  Motoyasu Sagawa, MD, Tsutomu Sakuma, MD, Tsugimasa Isobe, MD, Makoto Sugita,
Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients  Joachim Pfannschmidt,

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients  Joachim Pfannschmidt,
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Long-Term Survival With Chest Wall Resection and Pulmonary Metastasectomy for Hepatocellular Carcinoma  Shinya Ito, MD, PhD, Takashi Yoshimura, MD, PhD,

Long-Term Survival With Chest Wall Resection and Pulmonary Metastasectomy for Hepatocellular Carcinoma  Shinya Ito, MD, PhD, Takashi Yoshimura, MD, PhD,
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,
Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P

Hanan A. Tanash, PhD, Gerdt C. Riise, PhD, Magnus P
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Similar presentations

Ads by Google